Skip to main content

Moleculin Biotech, Inc 8-K, filed Nov 12, 2026

Moleculin Biotech, Inc. (MBRX)

8-K 2026-11-12 For: 2026-11-12
View Original
Added on November 12, 2026

About this 8-K

Moleculin Biotech, Inc filed this 8-K on November 12, 2026.

Moleculin Biotech announced Australian Patent No. 2020303572, covering preparation of preliposomal Annamycin lyophilizate, granted to Moleculin and The Board of Regents of The University of Texas System, strengthening intellectual property protection for its investigational anthracycline Annamycin. AI summary

Items reported

  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits